Eliminate all copays on generic prescription drugs for seniors and people with disabilities enrolled in Medicare Part D's Low Income Subsidy program.

Morgan McGarvey · Kentucky · Democratic

policy impact 0.78 specificity 0.93 extraction confidence 94%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

the introduced Cutting Copays Act would cut the cost of generic prescription drugs to $0 for over 270,000 Kentucky seniors and people with disabilities

McGarvey introduced legislation to eliminate copays on generic drugs for Medicare Part D LIS enrollees, including Kentucky seniors and people with disabilities.

Congressman McGarvey Introduces Legislation to Cap Drug Prices for Over 270,000 Kentucky Seniors, People With Disabilities | Congressman Morgan McGarvey of Kentucky's 3rd District
primary · other · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

Medicare.gov states that under Extra Help in 2026, beneficiaries pay a $0 premium and $0 deductible, but prescriptions at participating pharmacies can cost up to $5.10 for each generic drug. It also says beneficiaries pay $0 only after total drug costs reach $2,100, and QMB beneficiaries may still pay up to $4.90 for covered drugs.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Current official Medicare rules still allow generic drug copays for Part D Extra Help/Low Income Subsidy beneficiaries, so the promise to eliminate all generic copays has not been fully delivered as of 2026-07-02.

never later_term

Help with drug costs | Medicare
secondary · model gpt-5.5 · confidence 99%

Contest this evidence item

unverified · Source version 54976 · locator unknown

Congress.gov lists H.R.3069, the Medicare for All Act, as introduced on 2025-04-29 and referred to House committees. It lists Rep. Morgan McGarvey as an original cosponsor on 2025-04-29. The bill status is Introduced, not enacted.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): McGarvey took concrete legislative action in a later term by cosponsoring a broad no-cost-sharing health coverage bill, but it had not become law by the as-of date.

partial later_term A for effort

Cosponsors - H.R.3069 - 119th Congress (2025-2026): Medicare for All Act | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 95%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

The bill text includes outpatient prescription drugs among covered benefits and says no cost-sharing, including deductibles, coinsurance, copayments, or similar charges, may be imposed for benefits under the Act.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The bill McGarvey cosponsored would eliminate copays for covered prescription drug benefits if enacted, but it is only proposed legislation.

partial later_term A for effort

Text - H.R.3069 - 119th Congress (2025-2026): Medicare for All Act | Congress.gov
secondary · model gpt-5.5 · confidence 92%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

Congress.gov lists H.R.3421, the Medicare for All Act, as introduced on 2023-05-17, with Rep. Morgan McGarvey as an original cosponsor on 2023-05-17. The latest action was referral to the Subcommittee on Health on 2024-12-17, and the tracker status remained Introduced.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): During McGarvey's first House term, he cosponsored a broad no-cost-sharing health bill, but it did not pass or become law.

partial same_term A for effort

Cosponsors - H.R.3421 - 118th Congress (2023-2024): Medicare for All Act | Congress.gov
secondary · model gpt-5.5 · confidence 95%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

The 118th Congress bill text included outpatient prescription drugs in comprehensive benefits and barred cost-sharing, including copayments, for benefits provided under the Act.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): This first-term bill would have gone beyond the promise by eliminating copays for covered prescriptions generally, but it remained unenacted.

partial same_term A for effort

Text - H.R.3421 - 118th Congress (2023-2024): Medicare for All Act | Congress.gov
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

McGarvey's campaign health-care page says he supports Medicare for All, Medicare drug-price negotiation, and access to affordable prescription medication. The page does not state the specific Medicare Part D Low Income Subsidy generic-copay pledge verbatim.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official campaign material supports the broader health-care and prescription-drug affordability context, but it does not independently prove fulfillment of the precise LIS generic copay promise.

unresolved unknown

Morgan McGarvey on Health Care
campaign · model gpt-5.5 · confidence 63%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. unknown A for effort

The promised outcome has not been delivered: current Medicare Extra Help/LIS rules for 2026 still allow generic prescription copays, up to $5.10 before the applicable threshold. McGarvey did materially pursue related legislation by cosponsoring Medicare for All Act bills in the 118th and 119th Congresses that would bar prescription drug cost-sharing if enacted, but those bills remained introduced/not enacted. Because there was a serious legislative attempt without enactment of the specific copay elimination, this is a failed promise with an effort badge rather than partial delivery.

provider codex_cli · model gpt-5.5 · confidence 97%